These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9405657)

  • 1. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice.
    Wang YA; Elson A; Leder P
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14590-5. PubMed ID: 9405657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
    Lavin MF; Khanna KK
    Int J Radiat Biol; 1999 Oct; 75(10):1201-14. PubMed ID: 10549596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53-mediated DNA damage response to ionizing radiation in fibroblasts from ataxia-without-telangiectasia patients.
    Jongmans W; Vuillaume M; Kleijer WJ; Lakin ND; Hall J
    Int J Radiat Biol; 1998 Sep; 74(3):287-95. PubMed ID: 9737532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual roles of ATM in the cellular response to radiation and in cell growth control.
    Xu Y; Baltimore D
    Genes Dev; 1996 Oct; 10(19):2401-10. PubMed ID: 8843193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
    Kamijo T; van de Kamp E; Chong MJ; Zindy F; Diehl JA; Sherr CJ; McKinnon PJ
    Cancer Res; 1999 May; 59(10):2464-9. PubMed ID: 10344759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice.
    Xu Y; Yang EM; Brugarolas J; Jacks T; Baltimore D
    Mol Cell Biol; 1998 Jul; 18(7):4385-90. PubMed ID: 9632822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM: the product of the gene mutated in ataxia-telangiectasia.
    Lavin MF
    Int J Biochem Cell Biol; 1999 Jul; 31(7):735-40. PubMed ID: 10467728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles.
    Barlow C; Liyanage M; Moens PB; Deng CX; Ried T; Wynshaw-Boris A
    Nat Genet; 1997 Dec; 17(4):462-6. PubMed ID: 9398851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atm-deficient mice: a paradigm of ataxia telangiectasia.
    Barlow C; Hirotsune S; Paylor R; Liyanage M; Eckhaus M; Collins F; Shiloh Y; Crawley JN; Ried T; Tagle D; Wynshaw-Boris A
    Cell; 1996 Jul; 86(1):159-71. PubMed ID: 8689683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.
    Ziv S; Brenner O; Amariglio N; Smorodinsky NI; Galron R; Carrion DV; Zhang W; Sharma GG; Pandita RK; Agarwal M; Elkon R; Katzin N; Bar-Am I; Pandita TK; Kucherlapati R; Rechavi G; Shiloh Y; Barzilai A
    Hum Mol Genet; 2005 Oct; 14(19):2929-43. PubMed ID: 16150740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells.
    Fukao T; Kaneko H; Birrell G; Gatei M; Tashita H; Yoshida T; Cross S; Kedar P; Watters D; Khana KK; Misko I; Kondo N; Lavin MF
    Blood; 1999 Sep; 94(6):1998-2006. PubMed ID: 10477729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update.
    Lavin MF
    Radiother Oncol; 1998 May; 47(2):113-23. PubMed ID: 9683357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway.
    Pamment J; Ramsay E; Kelleher M; Dornan D; Ball KL
    Oncogene; 2002 Nov; 21(51):7776-85. PubMed ID: 12420214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways.
    Barlow C; Brown KD; Deng CX; Tagle DA; Wynshaw-Boris A
    Nat Genet; 1997 Dec; 17(4):453-6. PubMed ID: 9398849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells.
    Zhang N; Chen P; Gatei M; Scott S; Khanna KK; Lavin MF
    Oncogene; 1998 Aug; 17(7):811-8. PubMed ID: 9779997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection.
    Bai L; Kao JY; Law DJ; Merchant JL
    Gastroenterology; 2006 Sep; 131(3):841-52. PubMed ID: 16952553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Ataxia telangiectasia and the DNA-dependent protein kinase in the p53-mediated cellular response to ionising radiation.
    Jongmans W; Artuso M; Vuillaume M; Brésil H; Jackson SP; Hall J
    Oncogene; 1996 Sep; 13(6):1133-8. PubMed ID: 8808686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
    De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
    Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.
    Takagi M; Delia D; Chessa L; Iwata S; Shigeta T; Kanke Y; Goi K; Asada M; Eguchi M; Kodama C; Mizutani S
    Cancer Res; 1998 Nov; 58(21):4923-9. PubMed ID: 9810001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.